{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:44:50Z","timestamp":1767203090126,"version":"3.48.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"DOI":"10.7759\/cureus.100506","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:40:32Z","timestamp":1767202832000},"source":"Crossref","is-referenced-by-count":0,"title":["Fahr\u2019s Syndrome Secondary to Hypoparathyroidism Presenting With Neurological and Cardiac Manifestations"],"prefix":"10.7759","author":[{"given":"India","family":"Elliott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shailesh","family":"Dalvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"King","family":"Leong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2016.12.024","article-title":"Deconstructing Fahr's disease\/syndrome of brain calcification in the era of new genes","volume":"37","author":"Batla A","year":"2017","unstructured":"Batla A, Tai XY, Schottlaender L, Erro R, Balint B, Bhatia KP. Deconstructing Fahr's disease\/syndrome of brain calcification in the era of new genes. Parkinsonism Relat Disord. 2017, 37:1-10. 10.1016\/j.parkreldis.2016.12.024","journal-title":"Parkinsonism Relat Disord"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-019-03998-x","article-title":"Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features","volume":"40","author":"Donzuso G","year":"2019","unstructured":"Donzuso G, Mostile G, Nicoletti A, Zappia M. Basal ganglia calcifications (Fahr's syndrome): related conditions and clinical features. Neurol Sci. 2019, 40:2251-63. 10.1007\/s10072-019-03998-x","journal-title":"Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2004.12.001","article-title":"What is and what is not 'Fahr's disease'","volume":"11","author":"Manyam BV","year":"2005","unstructured":"Manyam BV. What is and what is not 'Fahr's disease'. Parkinsonism Relat Disord. 2005, 11:73-80. 10.1016\/j.parkreldis.2004.12.001","journal-title":"Parkinsonism Relat Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v7.i21.3662","article-title":"Hypoparathyroidism with Fahr's syndrome: a case report and review of the literature","volume":"7","author":"Zhou YY","year":"2019","unstructured":"Zhou YY, Yang Y, Qiu HM. Hypoparathyroidism with Fahr's syndrome: a case report and review of the literature. World J Clin Cases. 2019, 7:3662-70. 10.12998\/wjcc.v7.i21.3662","journal-title":"World J Clin Cases"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04353.x","article-title":"Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism","volume":"77","author":"Goswami R","year":"2012","unstructured":"Goswami R, Sharma R, Sreenivas V, Gupta N, Ganapathy A, Das S. Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Clin Endocrinol (Oxf). 2012, 77:200-6. 10.1111\/j.1365-2265.2012.04353.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.913382","article-title":"A case of seizure revealing Fahr's syndrome with primary hypoparathyroidism","volume":"19","author":"Lee YJ","year":"2018","unstructured":"Lee YJ, Park S, Kim YW, Park KM, Kim IH, Park JH, Park BS. A case of seizure revealing Fahr's syndrome with primary hypoparathyroidism. Am J Case Rep. 2018, 19:1430-3. 10.12659\/AJCR.913382","journal-title":"Am J Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4183\/aeb.2020.370","article-title":"Epileptic seizures as the first manifestation of Fahr's syndrome","volume":"16","author":"Manea MM","year":"2020","unstructured":"Manea MM, Sirbu A, Dragos D, Dobri AM, Sirbu AG, Tuta S. Epileptic seizures as the first manifestation of Fahr's syndrome. Acta Endocrinol (Buchar). 2020, 16:370-4. 10.4183\/aeb.2020.370","journal-title":"Acta Endocrinol (Buchar)"},{"key":"ref8","article-title":"Fahr\u2019s disease or Fahr\u2019s syndrome?","volume":"13","author":"Perugula ML","year":"2016","unstructured":"Perugula ML, Lippmann S. Fahr\u2019s disease or Fahr\u2019s syndrome?. Innov Clin Neurosci. 2016, 13:45-6.","journal-title":"Innov Clin Neurosci"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000515985","article-title":"Hypocalcemia-induced QT interval prolongation","volume":"147","author":"Tang JK","year":"2022","unstructured":"Tang JK, Rabkin SW. Hypocalcemia-induced QT interval prolongation. Cardiology. 2022, 147:191-5. 10.1159\/000515985","journal-title":"Cardiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.117.310230","article-title":"Calcium and excitation-contraction coupling in the heart","volume":"121","author":"Eisner DA","year":"2017","unstructured":"Eisner DA, Caldwell JL, Kistam\u00e1s K, Trafford AW. Calcium and excitation-contraction coupling in the heart. Circ Res. 2017, 121:181-95. 10.1161\/CIRCRESAHA.117.310230","journal-title":"Circ Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3941\/jrcr.v13i8.3633","article-title":"Intracranial calcifications on CT: an updated review","volume":"13","author":"Saade C","year":"2019","unstructured":"Saade C, Najem E, Asmar K, Salman R, El Achkar B, Naffaa L. Intracranial calcifications on CT: an updated review. J Radiol Case Rep. 2019, 13:1-18. 10.3941\/jrcr.v13i8.3633","journal-title":"J Radiol Case Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement","volume":"14","author":"Mantovani G","year":"2018","unstructured":"Mantovani G, Bastepe M, Monk D, et al.. Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement. Nat Rev Endocrinol. 2018, 14:476-500. 10.1038\/s41574-018-0042-0","journal-title":"Nat Rev Endocrinol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13082365","article-title":"Infectious diseases and basal ganglia calcifications: a cross-sectional study in patients with Fahr's disease and systematic review","volume":"13","author":"Snijders BM","year":"2024","unstructured":"Snijders BM, Peters MJ, van den Brink S, et al.. Infectious diseases and basal ganglia calcifications: a cross-sectional study in patients with Fahr's disease and systematic review. J Clin Med. 2024, 13:5. 10.3390\/jcm13082365","journal-title":"J Clin Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437653-fahrs-syndrome-secondary-to-hypoparathyroidism-presenting-with-neurological-and-cardiac-manifestations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T17:40:33Z","timestamp":1767202833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437653-fahrs-syndrome-secondary-to-hypoparathyroidism-presenting-with-neurological-and-cardiac-manifestations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,31]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.100506","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,31]]}}}